News Ipsen takes on BMS as kidney cancer pill launches in EU Cabometyx could take market share from Opdivo
News US regulator approves new use for Pfizer's Sutent FDA granted new kidney cancer indication despite advisers' split decision
News FDA advisers split on new kidney cancer use for Pfizer's Sut... Committee could not decide if Sutent can be used after the removal of a cancerous kidney.
News EUSA Pharma's Fotivda approved in EU for kidney cancer UK pharma gets licence for second cancer drug
News BMS shares fall after latest Opdivo disappointment BMS waiting for overall survival data of Opdivo and Yervoy in kidney cancer
News EUSA Pharma looks to further in-licensing to build growth Specialist company EUSA Pharma is looking for new medicines to develop after getting two cancer drugs recommended by European regulators this year.
News Protego's $130m for amyloidosis drug, and other financings Our latest crop of biotech financings has nine-figure rounds for Protego and Triana, with Excelsior Sciences and SciNeuro also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
